Interplexus, Inc – Trademark Portfolio
Entity Type: 03
Interplexus, Inc holds 18 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 16 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include FURA-MAG, THYRO-DYNE, FLAVO PLEXC, INTERPLEXUS, and IPX-BOOSTER. The owner is based in Kent, WA.
6613 S 192nd Place #K103
Kent, WA 98032
Showing of trademarks Trademarks
Trademark Classifications
Interplexus, Inc's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Interplexus, Inc have?
Interplexus, Inc has 18 U.S. trademarks filed with the USPTO. Of these, 7 registered, 5 abandoned, 6 cancelled.
What trademark classes does Interplexus, Inc file in?
Interplexus, Inc files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Interplexus, Inc's most well-known trademarks?
Interplexus, Inc's registered trademark portfolio includes well-known marks such as FURA-MAG, THYRO-DYNE, FLAVO PLEXC, INTERPLEXUS, and IPX-BOOSTER. These are among 7 currently registered trademarks in the portfolio.
What is Interplexus, Inc's trademark registration success rate?
Interplexus, Inc has a 39% trademark registration rate, with 7 out of 18 resolved applications resulting in successful registration. Currently, 0 applications are pending review.